WHO ICTRP trial
Herba Leonuri Injection for Postpartum Hemorrhage Preservation and Uterus…
ChiCTR-TRC-08000136 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-08000136 |
|---|---|
| Public title | Herba Leonuri Injection for Postpartum Hemorrhage Preservation and Uterus Involution Promotion: A Phase 4,Multicentre Randomized Controlled Trial |
| Scientific title | Herba Leonuri Injection for Postpartum Hemorrhage Preservation and Uterus Involution Promotion: A Phase 4,Multicentre Randomized Controlled Trial |
| Primary sponsor | Renji Hospital affiliated to Medical School, Shanghai Jiaotong University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | Hemorrhage post caesarean section, spontaneous delivery and surgical abortion |
| Interventions | Herba Leonuri group:After fetal delivery,firstly, give Herba Leonuri 40mg into uterus by intramuscular injection, then Herba Leonuri 40mg ,q12h for 3 times by intragluteal injection.;Herba Leonuri and Oxytocin group:After fetal delivery… |
| Registration date | Aug 12, 2008 |
| Target size | Herba Leonuri group:450;Herba Leonuri and Oxytocin group:450;Oxytocin group:120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: